A Novel Balanced Dual Vasopressin V1a/V2 Receptor Antagonist for Treatment of Congestive Heart Failure: Results From a First-in-Man Study

被引：0
|
作者：
Pimenta, Eduardo
Jensen, Markus
Jung, David
Lobmeyer, Maximilian
Schmitt, Walter
Schaumann, Frank
Boxnick, Stefanie
Truebel, Hubert
机构：
来源：
CIRCULATION | 2017年 / 136卷
关键词：
Heart failure; Vasopressins; Abdominal aortic aneurysm;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
15196
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effect of conivaptan, a combined vasopressin V1a and V2 receptor antagonist, on vasopressin-induced cardiac and haemodynamic changes in anaesthetised dogs
    Yatsu, T
    Kusayama, T
    Tomura, Y
    Arai, Y
    Aoki, M
    Tahara, A
    Wada, K
    Tsukada, J
    PHARMACOLOGICAL RESEARCH, 2002, 46 (05) : 375 - 381
  • [42] Vasopressin V1a and V2 receptor mRNA in deoxycorticosterone acetate salt hypertension in the rat
    Risvanis, J
    Johnston, CI
    Phillips, PA
    Burrell, LM
    CLINICAL SCIENCE, 1998, 94 (05) : 517 - 523
  • [43] Hemodynamic effects of conivaptan hydrochloride (YM087, CI-1025) a combined vasopressin V1A and V2 receptor antagonist in patients with advanced heart failure
    Udelson, JE
    Smith, WB
    Hendrix, GH
    Painchaud, CA
    Ghazzi, MM
    Thomas, I
    Ghali, JK
    Selaru, P
    Pressler, ML
    Konstam, MA
    CIRCULATION, 2000, 102 (18) : 593 - 593
  • [44] Haemodynamic effects of conivaptan hydrochloride (YM087, CI-1025) a combined vasopressin V1A and V2 receptor antagonist, in patients with advanced heart failure
    Udelson, J
    Smith, WB
    Hendrix, G
    Painchaud, C
    Ghazzi, MM
    Thomas, I
    Ghali, J
    Selaru, P
    Pressler, M
    Konstam, M
    EUROPEAN HEART JOURNAL, 2001, 22 : 394 - 394
  • [45] The magnocellular vasopressin neurones of the rat hypothalamus express V1a and V1b but not V2 vasopressin receptor mRNAs
    Hurbin, A
    Boissin-Agasse, L
    Orcel, H
    Rabié, A
    Joux, N
    Desarménien, MG
    Richard, P
    Moos, FC
    JOURNAL OF PHYSIOLOGY-LONDON, 1998, 509P : 87P - 87P
  • [46] Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist
    Kolkhof, Peter
    Pook, Elisabeth
    Pavkovic, Mira
    Kretschmer, Axel
    Buchmueller, Anja
    Tinel, Hanna
    Delbeck, Martina
    Mondritzki, Thomas
    Wasnaire, Pierre
    Dinh, Wilfried
    Truebel, Hubert
    Hueser, Joerg
    Schmeck, Carsten
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (01) : 44 - 52
  • [47] Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study
    Goldsmith, Steven R.
    Elkayam, Uri
    Haught, W. Herbert
    Barve, Abhijit
    He, Weizhong
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (08) : 641 - 647
  • [48] Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet-cold pattern
    Matsushita, Kenichi
    Harada, Kazumasa
    Miyamoto, Takamichi
    Iida, Kiyoshi
    Yamamoto, Yoshiya
    Shiraishi, Yasuyuki
    Nagatomo, Yuji
    Yoshino, Hideaki
    Yamamoto, Takeshi
    Nagao, Ken
    Takayama, Morimasa
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (11) : 1795 - 1805
  • [49] Treatment of hyponatraemia in patients with SIADH or CHF with intravenous conivaptan (YM087), a new combined vasopressin V1A/V2 receptor antagonist
    Abraham, W
    Koren, M
    Bichet, DG
    Verbalis, JG
    Klapholz, M
    Selaru, P
    Bakker-Arkema, RG
    Rummel, SA
    EUROPEAN HEART JOURNAL, 2000, 21 : 345 - 345
  • [50] Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure
    Veeraveedu, Punniyakoti T.
    Watanabe, Kenichi
    Ma, Meilei
    Palaniyandi, Suresh S.
    Yamaguchi, Ken'ichi
    Suzuki, Kenji
    Kodama, Makoto
    Aizawa, Yoshifusa
    BIOCHEMICAL PHARMACOLOGY, 2007, 74 (10) : 1466 - 1475
12345